Case reports in transplantationCardiacTotal Artificial Heart Bridge to Transplantation for a Patient With Occult Intracardiac Malignancy: Case Report
Section snippets
Case Report
A 51-year-old man with dilated cardiomyopathy presented with left ventricular ejection fraction of 10–15%, left ventricular end-diastolic dimension of 8.6 cm, and continuous intravenous inotrope dependence. Right heart catheterization and echocardiography demonstrated biventricular failure without any findings suggestive of an intracardiac mass. He had recurrent episodes of symptomatic ventricular tachycardia and ventricular fibrillation, intolerance to inotropes and antiarrhythmics, and
Comment
For critically ill patients with refractory biventricular failure and/or arrhythmias, total artificial heart implantation improves survival to heart transplantation (79%) compared to no device (46%). TAH bridge to transplantation post-transplant survival at 1 and 5 years (86% and 64%) is similar to contemporary UNOS survival rates (84.7% and 69.8%) [2]. Survival 1 year after implantation is similar for TAH (59%) and continuous flow biventricular assist devices (BiVADs, 57%), with further
References (12)
- et al.
Survival after biventricular mechanical circulatory support: does the type of device matter?
J Heart Lung Transplant
(2012) - et al.
Survival to transplant in patients undergoing mechanical circulatory support as bridge: retrospective analysis of LVAD, BiVAD and TAH strategy
J Heart Lung Transplant
(2012) - et al.
Sequential therapy of primary cardiac lymphoma with cardiectomy, total artificial heart support, and cardiac transplantation
J Heart Lung Transplant
(2010) - et al.
Large cardiac tumor managed with resection and two ventricular assist devices
Ann Thorac Surg
(2014) - et al.
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006
J Heart Lung Transplant
(2006) - et al.
Heart disease and stroke statistics–2013 update: a report from the American Heart Association
Circulation
(2013)
Cited by (5)
Cardiac tumors invading the right ventricle; Aggressive Surgical Management with backup mechanical circulatory support if necessary: Aggressive Surgical Management of Cardiac Tumors
2020, Surgical OncologyCitation Excerpt :Should the patient remain free of recurrence of disease during a monitoring phase, would then be listed for cardiac transplantation. This concept has been employed previously by three groups [6–8]. Of these, two patients did not survive the perioperative period and died in intensive care, one was successfully transplanted after 14 months of support and remains tumor free after three years.
Heart Failure Therapies for End-Stage Chemotherapy–Induced Cardiomyopathy
2016, Journal of Cardiac FailureCitation Excerpt :TAH support with full replacement of the native heart has been used in a small fraction of patients with need for durable biventricular support,50 mostly as BTT. The use of TAH in CCMP patients with biventricular failure as BTT has been described in case reports for either very rare primary cardiac malignancies67 or CCMP patients60,68 as BTT. The ability to provide biventricular support in patients with severe biventricular failure or to explant the heart in rare primary cardiac tumors may be served with TAH support in these infrequent cases as BTT or as DT therapy59 for patients who are ineligible for transplantation.
Application of total artificial heart in patients with primary malignant cardiac tumors-current treatment strategies
2020, Annals of Cardiothoracic SurgeryTotal artificial heart implantation after right ventricular intimal spindle cell sarcoma
2019, European Journal of Cardio-thoracic Surgery2019 EACTS Expert Consensus on long-term mechanical circulatory support
2019, European Journal of Cardio-thoracic Surgery